Skip to main content

PET imaging with hypoxia tracers: a must in radiation therapy

European Journal of Nuclear Medicine and Molecular Imaging volume 35, pages 838–842 (2008)Cite this article

An Erratum to this article was published on 19 March 2008

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007;26(2):225-39. Jun.

    CAS  Article  PubMed  Google Scholar 

  2. Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KS, et al. Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol. 2006;82(10):699-757. Oct.

    CAS  Article  PubMed  Google Scholar 

  3. Lee ST, Scott AM. Hypoxia positron emission tomography imaging with 18F-fluoromisonidazole. Semin Nucl Med. 2007;37(6):451-61. Nov.

    Article  PubMed  Google Scholar 

  4. Vāvere AL, Lewis JS. Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia. Dalton Trans. 2007;21(43):4893-902. Nov.

    Article  Google Scholar 

  5. Piert M, Machulla HJ, Picchio M, Reischl G, Ziegler S, Kumar P, et al. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside. J Nucl Med. 2005;46(1):106-13. Jan.

    PubMed  Google Scholar 

  6. Padhani AR, Krohn KA, Lewis JS, Alber M. Imaging oxygenation of human tumours. Eur Radiol. 2007;17(4):861-72. Apr.

    Article  PubMed  Google Scholar 

  7. Nehmeh SA, Lee NY, Schröder H, Squire O, Zanzonico PB, Erdi YE, et al. Reproducibility of intratumor distribution of (18)f-fluoromisonidazole in head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;70(1):235-42. Jan 1.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. Eschmann SM, Paulsen F, Bedeshem C, Machulla HJ, Hehr T, Bamberg M, et al. Hypoxia-imaging with [18F]-misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer. Radiother Oncol. 2007;83(3):406-10. Jun.

    CAS  Article  PubMed  Google Scholar 

  9. Thorwarth D, Eschmann SM, Paulsen F, Alber M. A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations. Int J Radiat Oncol Biol Phys. 2007;68(2):515-21. Jun 1.

    CAS  Article  PubMed  Google Scholar 

  10. Grigsby PW, Malyapa RS, Higashikubo R, Schwarz JK, Welch MJ, Huettner PC, et al. Comparison of molecular markers of hypoxia and imaging with 60Cu-ATSM in cancer of the uterine cervix. Mol Imaging Biol. 2007;9(5):278-83. Sep-Oct.

    Article  PubMed  Google Scholar 

  11. Souvatzoglou M, Grosu AL, Röper B, Krause BJ, Beck R, Reischl G, et al. Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study. Eur J Nucl Med Mol Imaging. 2007;34(10):1566-75. Oct.

    CAS  Article  PubMed  Google Scholar 

  12. Grosu AL, Souvatzoglou M, Röper B, Dobritz M, Wiedenmann N, Jacob V, et al. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;69(2):541-51. Oct 1.

    CAS  Article  PubMed  Google Scholar 

  13. Lee NY, Mechalakos JG, Nehmeh S, Lin Z, Squire OD, Cai S, et al. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys. 2008;70(1):2-13. Jan 1.

    CAS  Article  PubMed  Google Scholar 

  14. Reischl G, Dorow DS, Cullinane C, Katsifis A, Roselt P, Binns D, et al. Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA—first small animal PET results. J Pharm Pharm Sci. 2007;10(2):203-11.

    CAS  PubMed  Google Scholar 

  15. Lecchi M, Fossati P, Elisei F, Orecchia R, Lucignani G. Current concepts on imaging in radiotherapy. Eur J Nucl Med Mol Imaging. 2007; DOI 10.1007/s00259-007-0631-y, Oct 31; [Epub ahead of print].

  16. Krause BJ, Beck R, Souvatzoglou M, Piert M. PET and PET/CT studies of tumor tissue oxygenation. Q J Nucl Med Mol Imaging. 2006;50(1):28-43. Mar.

    CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Institute of Radiological Sciences, University of Milan, Unit of Nuclear Medicine, Hospital San Paolo, Via Antonio di Rudinì, 8, 20142, Milan, Italy

    Giovanni Lucignani

Authors
  1. Giovanni Lucignani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanni Lucignani.

Additional information

This commentary derives from a literature search of recently published articles and draws extensively on the texts of the articles referenced.

An Erratum for this chapter can be found at http://dx.doi.org/10.1007/s00259-008-0764-7

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lucignani, G. PET imaging with hypoxia tracers: a must in radiation therapy. Eur J Nucl Med Mol Imaging 35, 838–842 (2008). https://doi.org/10.1007/s00259-008-0740-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-008-0740-2

Keywords

  • Positron Emission Tomography
  • Standardise Uptake Value
  • Positron Emission Tomography Imaging
  • Tumour Hypoxia
  • Tirapazamine